Axsome Therapeutics AXSM Q2 2025 earnings
Reported August 4, 2025 · Before market open
Revenue$150.0MBeat by $10.0M
EPS-$0.92Beat by $0.08
Revenue estimate$140.0M
EPS estimate-$1.00
Next report
Aug 10, 2026 (In 1 week)Revenue estimate$220.9M
EPS estimate-$0.89
Financials
Q2 2025Valuation & ratios
Versus estimates
Revenue
Diluted EPS
Ask the moment Axsome Therapeutics reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did Axsome Therapeutics report Q2 2025 earnings?
- Axsome Therapeutics (AXSM) reported Q2 2025 earnings on August 4, 2025 before market open.
- What were Axsome Therapeutics's Q2 2025 revenue and EPS?
- Axsome Therapeutics reported revenue of $150.0M and eps of $-0.92 for Q2 2025.
- Did Axsome Therapeutics beat estimates in Q2 2025?
- Revenue beat the consensus estimate of $140.0M by $10.0M. EPS beat the consensus estimate of $-1.00 by $0.08.
- How did Axsome Therapeutics's Q2 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue grew 72.1% from $87.2M a year earlier and eps grew 25.8% from $-1.24.
- Where can I find Axsome Therapeutics's Q2 2025 SEC filings?
- You can read the 10-Q periodic report (0000950170-25-102148) directly on SEC EDGAR. The filing index links above go to sec.gov.